Published in Hepatitis Weekly, September 12th, 2005
According to a study from Germany, "recurrence of hepatitis C virus (HCV) infection after orthotopic liver transplantation (OLT) is a virtually universal occurrence, and a significant proportion of patients develop chronic hepatitis and cirrhosis. The aim of this study was to evaluate the safety and efficacy of interferon (IFN)-alpha 2b plus ribavirin (RIBA) in the treatment of recurrent HCV after OLT over the long term."
"Fifteen patients with recurrent HCV infection...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly